Mint Tower Capital Management B.V. 89bio, Inc. Transaction History
Mint Tower Capital Management B.V.
- $844 Million
- Q3 2025
A detailed history of Mint Tower Capital Management B.V. transactions in 89bio, Inc. stock. As of the latest transaction made, Mint Tower Capital Management B.V. holds 70,000 shares of ETNB stock, worth $1.04 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
70,000Holding current value
$1.04 Million% of portfolio
0.12%Shares
1 transactions
Others Institutions Holding ETNB
# of Institutions
233Shares Held
160MCall Options Held
710KPut Options Held
6.17M-
Ra Capital Management, L.P. Boston, MA19.9MShares$295 Million5.01% of portfolio
-
Pentwater Capital Management LP Naples, FL11.8MShares$174 Million1.08% of portfolio
-
Deep Track Capital, LP Greenwich, CT9.36MShares$139 Million4.33% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.1MShares$135 Million0.22% of portfolio
-
Suvretta Capital Management, LLC New York, NY8.28MShares$123 Million3.65% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $690M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...